These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24633177)

  • 21. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma.
    Chan KL; Guan XY; Ng IO
    Hum Pathol; 2004 Nov; 35(11):1324-31. PubMed ID: 15668888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptomic analyses of oncogenic hepatocytes reveal common and different molecular pathways of hepatocarcinogenesis in different developmental stages and genders in kras
    Huo X; Li H; Li Z; Yan C; Mathavan S; Liu J; Gong Z
    Biochem Biophys Res Commun; 2019 Mar; 510(4):558-564. PubMed ID: 30739784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crosstalk of Ras and Rho: activation of RhoA abates Kras-induced liver tumorigenesis in transgenic zebrafish models.
    Chew TW; Liu XJ; Liu L; Spitsbergen JM; Gong Z; Low BC
    Oncogene; 2014 May; 33(21):2717-27. PubMed ID: 23812423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of glycosylphosphatidylinositol-anchored proteins and GPI-phospholipase D in a c-Myc transgenic mouse model of hepatocellular carcinoma and human HCC.
    Ritorto MS; Rhode H; Vogel A; Borlak J
    Biol Chem; 2016 Nov; 397(11):1147-1162. PubMed ID: 27232633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver-specific androgen receptor knockout attenuates early liver tumor development in zebrafish.
    Li H; Li Y; Lu JW; Huo X; Gong Z
    Sci Rep; 2019 Jul; 9(1):10645. PubMed ID: 31337771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. c-Myc-driven Hepatocarcinogenesis.
    Moon H; Park H; Ro SW
    Anticancer Res; 2021 Oct; 41(10):4937-4946. PubMed ID: 34593441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-494 within an oncogenic microRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer.
    Lim L; Balakrishnan A; Huskey N; Jones KD; Jodari M; Ng R; Song G; Riordan J; Anderton B; Cheung ST; Willenbring H; Dupuy A; Chen X; Brown D; Chang AN; Goga A
    Hepatology; 2014 Jan; 59(1):202-15. PubMed ID: 23913442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
    Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
    Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of combined hepatocellular-cholangiocarcinoma through transdifferentiation and dedifferentiation in p53-knockout mice.
    Liu Y; Xin B; Yamamoto M; Goto M; Ooshio T; Kamikokura Y; Tanaka H; Meng L; Okada Y; Mizukami Y; Nishikawa Y
    Cancer Sci; 2021 Aug; 112(8):3111-3124. PubMed ID: 34051011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver-specific expressions of HBx and src in the p53 mutant trigger hepatocarcinogenesis in zebrafish.
    Lu JW; Yang WY; Tsai SM; Lin YM; Chang PH; Chen JR; Wang HD; Wu JL; Jin SL; Yuh CH
    PLoS One; 2013; 8(10):e76951. PubMed ID: 24130815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of Akt/PKB and IKK complex in constitutive induction of NF-kappaB in hepatocellular carcinomas of transforming growth factor alpha/c-myc transgenic mice.
    Factor V; Oliver AL; Panta GR; Thorgeirsson SS; Sonenshein GE; Arsura M
    Hepatology; 2001 Jul; 34(1):32-41. PubMed ID: 11431731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered methionine metabolism and global DNA methylation in liver cancer: relationship with genomic instability and prognosis.
    Calvisi DF; Simile MM; Ladu S; Pellegrino R; De Murtas V; Pinna F; Tomasi ML; Frau M; Virdis P; De Miglio MR; Muroni MR; Pascale RM; Feo F
    Int J Cancer; 2007 Dec; 121(11):2410-20. PubMed ID: 17680562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of hepatocarcinogenesis by neutrophils upon induction of oncogenic kras expression in transgenic zebrafish.
    Yan C; Huo X; Wang S; Feng Y; Gong Z
    J Hepatol; 2015 Aug; 63(2):420-8. PubMed ID: 25828472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma.
    Orimo T; Ojima H; Hiraoka N; Saito S; Kosuge T; Kakisaka T; Yokoo H; Nakanishi K; Kamiyama T; Todo S; Hirohashi S; Kondo T
    Hepatology; 2008 Dec; 48(6):1851-63. PubMed ID: 18937283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis.
    Bai HY; Liao YJ; Cai MY; Ma NF; Zhang Q; Chen JW; Zhang JX; Wang FW; Wang CY; Chen WH; Jin XH; Xu RH; Guan XY; Xie D
    Stem Cells; 2018 Feb; 36(2):180-191. PubMed ID: 29119708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
    Ritorto MS; Borlak J
    J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors.
    Zhang XK; Huang DP; Qiu DK; Chiu JF
    Oncogene; 1990 Jun; 5(6):909-14. PubMed ID: 2163054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.
    Newell P; Toffanin S; Villanueva A; Chiang DY; Minguez B; Cabellos L; Savic R; Hoshida Y; Lim KH; Melgar-Lesmes P; Yea S; Peix J; Deniz K; Fiel MI; Thung S; Alsinet C; Tovar V; Mazzaferro V; Bruix J; Roayaie S; Schwartz M; Friedman SL; Llovet JM
    J Hepatol; 2009 Oct; 51(4):725-33. PubMed ID: 19665249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
    Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
    Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.